COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 1386: Articles 13851-13860  | Next

Low uptake of COVID-19 lateral flow testing among university students: a mixed methods evaluation
French, C. E., Denford, S., Brooks-Pollock, E., Wehling, H., Hickman, M.
10.1101/2021.07.20.21260836 — Posted: 2021-07-22
Increased transmissibility of emerging SARS-CoV-2 variants is driven either by viral load or probability of infection rather than environmental stability
Arav, Y., Fattal, E., Klausner, Z.
10.1101/2021.07.19.21260707 — Posted: 2021-07-22
SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021
Cohen, C., Kleynhans, J., von Gottberg, A., McMorrow, M., Wolter, N., Bhiman, J., Moyes, J., du Plessis, M., Carrim, M., Buys, A., Martinson, N. A., Kahn, K., Tollman, S., Lebina, L., Wafawanaka, F., du Toit, J., Gomez-Olive, F. X., Dawood, F., Mkhencele, T., Sun, K., Viboud, C., Tempia, S.
10.1101/2021.07.20.21260855 — Posted: 2021-07-22
Prevalence of SARS CoV-2 infection among Health Care Workers of a hybrid tertiary COVID 19 hospital in Kerala
S J, J., Beegum, S., Gopakumar, G., G, B., S, C., Sasidharan, S., Tonio, A., REGHUKUMAR, A.
10.1101/2021.07.19.21260792 — Posted: 2021-07-22
Antibody responses to BNT162b2 vaccination in Japan: Monitoring vaccine efficacy by measuring IgG antibodies against the receptor binding domain of SARS-CoV-2
Fujigaki, H., Yamamoto, Y., Koseki, T., Banno, S., Ando, T., Ito, H., Fujita, T., Naruse, H., Hata, T., Moriyama, S., Takahashi, Y., Suzuki, T., Murakami, T., Yoshida, Y., Yagura, Y., Oyamada, T., Takemura, M., Kondo, M., Iwata, M., Saito, K.
10.1101/2021.07.19.21260728 — Posted: 2021-07-22
Clinical and Virological Response to a Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19
Lundgren, J. D., ACTIV-3/TICO Bamlanivimab Study Group
10.1101/2021.07.19.21260559 — Posted: 2021-07-22
Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)
Martin, B., DeWitt, P. E., Russell, S., Anand, A., Bradwell, K. R., Bremer, C., Gabriel, D., Girvin, A. T., Hajagos, J. G., McMurry, J. A., Neumann, A. J., Pfaff, E. R., Walden, A., Wooldridge, J. T., Yoo, Y. J., Saltz, J., Gersing, K. R., Chute, C. G., Haendel, M. A., Moffitt, R., Bennett, T. D.
10.1101/2021.07.19.21260767 — Posted: 2021-07-22 Discussion: Onsite
Effectiveness of the ChAdOx1 vaccine in the elderly during SARS-CoV-2 Gamma variant transmission in Brazil
Hitchings, M., Ranzani, O. T., Dorion, M., D'Agostini, T. L., de Paula, R. C., de Paula, O. F. P., Villela, E. F. d. M., Torres, M. S. S., de Oliveira, S. B., Schulz, W., Almiron, M., Said, R., de Oliveira, R. D., da Silva, P. V., de Araujo, W. N., Gorinchteyn, J. C., Andrews, J. R., Cummings, D. A. T., Ko, A., Croda, J.
10.1101/2021.07.19.21260802 — Posted: 2021-07-22
RNA viromics of Southern California wastewater and detection of SARS-CoV-2 single nucleotide variants.
Rothman, J. A., Loveless, T. B., Kapcia, J., Adams, E. D., Steele, J. A., Zimmer-Faust, A. G., Langlois, K., Wanless, D., Griffith, M., Mao, L., Chokry, J., Griffith, J. F., Whiteson, K. L.
10.1101/2021.07.19.21260815 — Posted: 2021-07-22
Assessing COVID prevention strategies to permit the safe opening of college campuses in fall 2021
Paltiel, A. D., Schwartz, J. L.
10.1101/2021.07.19.21260522 — Posted: 2021-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).